Home > government control > Big Pharma attempting to corner the market on medical marijuana

Big Pharma attempting to corner the market on medical marijuana

“As DEA raids and IRS harassment continue on state-approved medical marijuana, Big Pharma eyes the profitability of cannabis and prepares to muscle in, using its lobbyists and government connections to ensure a monopoly on legal sales of the drug.

In early April of 2011, two drug manufacturing giants, G.W. Pharmaceuticals and Novartis, announced they had formed an alliance to license and market GW’s Sativex, a liquid cannabis drug. The drug is already available in Great Britain, as well as Canada and Spain. The licensing agreement with Novartis will enable sales to expand into markets in Africa, Asia and the Middle East. FDA Phase III trials are still being organized for Otsuka, GW’s partner for licensing Sativex for the US market.”

Via Natural News

About these ads
Categories: government control
  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 887 other followers

%d bloggers like this: